PCVX Company Profile and Key Details

Q: Who are the executives of PCVX?

Mr. Harp Dhaliwal M.B.A.Senior Vice President of Commercial Manufacturing & Supply ChainMs. Janet GraesserVice President of Corporation Communications & Investor RelationsMs. Elvia CowanSenior Vice President of Fin. & Principal Accounting OfficerKaren AldereteExecutive Director of HRMr. Grant E. Pickering M.B.A.Co-Founder, Chief Executive Officer & DirectorDr. Jeff Fairman Ph.D.Co-Founder & Vice President of ResearchDr. Ashish Khanna M.B.A., Ph.D.Co-FounderMr. Andrew L. Guggenhime M.B.A.Pres, Chief Financial Officer & Principal Accounting OfficerMr. James Wassil M.B.A., M.S.Executive Vice President & Chief Operating OfficerMr. Paul W. Sauer M.B.A., MBASenior Vice President of Process Devel. & ManufacturingMr. Mikhail Eydelman J.D.Senior Vice President, Gen. Counsel, Chief Compliance Officer & Corporation Sec.

NASDAQ : PCVX

Vaxcyte

$58.13

-2.24-3.71%

At Close 4:00 PM

60.86

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Vaxcyte, Inc. (PCVX) stock declined over -3.71%, trading at $58.13 on NASDAQ, down from the previous close of $60.37. The stock opened at $59.79, fluctuating between $57.02 and $60.37 in the recent session.

Stock Snapshot

60.37

Prev. Close

8.39B

Market Cap

57.02

Day Low

-7.62

P/E Ratio

-7.63

EPS (TTM)

-3.82

Cash Flow per Share

59.79

Open

144.4M

Number of Shares

60.37

Day High

90%

Free Float in %

13.01

Book Value

2.71M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 18, 2026	60.37	60.37	57.01	58.13	2.71M
Sep 17, 2026	60.22	61.50	59.31	60.37	1.31M
Sep 16, 2026	59.25	60.13	58.40	58.77	1.25M
Sep 15, 2026	59.70	59.75	58.19	59.21	1.89M
Sep 14, 2026	60.04	60.85	59.09	59.54	1.43M
Sep 11, 2026	60.07	60.20	58.21	59.47	1.68M
Sep 10, 2026	59.19	60.13	58.56	58.90	1.16M
Sep 09, 2026	59.99	60.33	59.05	59.51	1.2M
Sep 08, 2026	60.25	61.03	59.22	60.36	1.02M
Sep 04, 2026	59.73	61.78	59.65	61.16	986.69K
Sep 03, 2026	61.73	62.14	59.85	61.17	736.46K
Sep 02, 2026	61.63	62.90	60.82	61.58	1.02M
Sep 01, 2026	60.29	62.14	60.06	60.81	1.44M
Aug 31, 2026	59.10	61.61	58.51	60.74	1.52M
Aug 28, 2026	61.06	62.38	59.49	59.84	759.73K
Aug 27, 2026	60.51	61.60	59.93	61.16	611.54K
Aug 26, 2026	61.04	61.65	60.32	61.09	891.3K
Aug 25, 2026	62.22	63.92	60.96	61.09	1.22M
Aug 24, 2026	62.30	63.05	61.23	61.87	662.1K
Aug 21, 2026	61.60	63.98	61.60	62.62	1.14M

Contact Details

San Carlos, CA 94070

United States

https://vaxcyte.com 650 837 0111

About Company

Vaxcyte, Inc. is a biotechnology firm in the clinical development stage, dedicated to creating innovative protein-based vaccines. Its primary objective is to either prevent or manage bacterial infectious diseases. The company's leading vaccine candidate is VAX-24, an experimental 24-valent pneumococcal conjugate vaccine currently undergoing Phase 1/2 clinical trials, intended to address invasive pneumococcal disease and pneumonia. Beyond its flagship candidate, Vaxcyte is also advancing several other vaccine programs: VAX-XP, designed to offer protection against emergent bacterial strains and counter antimicrobial resistance; VAX-A1, a conjugate vaccine formulation aimed at Group A Streptococcus; and VAX-PG, a novel protein vaccine specifically developed to target the key pathogen responsible for periodontitis. The organization, which was initially established as SutroVax, Inc., officially rebranded as Vaxcyte, Inc. in May 2020. Founded in 2013, its corporate headquarters are situated in San Carlos, California.

Stock Peers

ARGX

-5.45-0.55%

argenx SE$990.32 REGN

-4.6-0.58%

Regeneron Pharmaceuticals, Inc.$784.85 MDGL

-2.88-0.54%

Madrigal Pharmaceuticals, Inc.$531.52 VRTX

-8.20008-1.59%

Vertex Pharmaceuticals Incorporated$508.14 UTHR

-2.64-0.53%

United Therapeutics Corporation$494.63 ONC

-2.62-0.74%

BeOne Medicines AG$350.84 KRYS

-2.08-0.61%

Krystal Biotech, Inc.$336.67 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

-11.52-3.71%

Praxis Precision Medicines, Inc.$298.95 LGND

-1.21-0.43%

Ligand Pharmaceuticals Incorporated$283.49

Frequently Asked Questions

What is the current Vaxcyte, Inc. (PCVX) stock price?

Vaxcyte, Inc. (NASDAQ: PCVX) stock price is $58.13 in the last trading session. During the trading session, PCVX stock reached the peak price of $60.37 while $57.02 was the lowest point it dropped to. The percentage change in PCVX stock occurred in the recent session was -3.71% while the dollar amount for the price change in PCVX stock was - $2.24.

PCVX's industry and sector of operation?

The NASDAQ listed PCVX is part of Biotechnology industry that operates in the broader Healthcare sector. Vaxcyte, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PCVX?

Mr. Harp Dhaliwal M.B.A.
Senior Vice President of Commercial Manufacturing & Supply Chain
Ms. Janet Graesser
Vice President of Corporation Communications & Investor Relations
Ms. Elvia Cowan
Senior Vice President of Fin. & Principal Accounting Officer
Karen Alderete
Executive Director of HR
Mr. Grant E. Pickering M.B.A.
Co-Founder, Chief Executive Officer & Director
Dr. Jeff Fairman Ph.D.
Co-Founder & Vice President of Research
Dr. Ashish Khanna M.B.A., Ph.D.
Co-Founder
Mr. Andrew L. Guggenhime M.B.A.
Pres, Chief Financial Officer & Principal Accounting Officer
Mr. James Wassil M.B.A., M.S.
Executive Vice President & Chief Operating Officer
Mr. Paul W. Sauer M.B.A., MBA
Senior Vice President of Process Devel. & Manufacturing
Mr. Mikhail Eydelman J.D.
Senior Vice President, Gen. Counsel, Chief Compliance Officer & Corporation Sec.

How PCVX did perform over past 52-week?

PCVX's closing price is 88.18% higher than its 52-week low of $30.89 where as its distance from 52-week high of $65.00 is -10.57%.

How many employees does PCVX have?

Number of PCVX employees currently stands at 507.

Link for PCVX official website?

Official Website of PCVX is: https://vaxcyte.com

How do I contact PCVX?

PCVX could be contacted at phone 650 837 0111 and can also be accessed through its website. PCVX operates from 825 Industrial Road, San Carlos, CA 94070, United States.

How many shares of PCVX are traded daily?

PCVX stock volume for the day was 2.71M shares. The average number of PCVX shares traded daily for last 3 months was 1.28M.

What is the market cap of PCVX currently?

The market value of PCVX currently stands at $8.39B with its latest stock price at $58.13 and 144.4M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	507
Beta	1.22
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	507
Beta	1.22
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

PCVX Company Profile and Key Details

Vaxcyte

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Dividend & Fair Value

Shareholding & Insider Activity

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook